Skip to main content
Veterinary Medicines

Noroclox DC 500 mg suspensija ievadīšanai tesmenī liellopiem

Authorised
  • Cloxacillin

Product identification

Medicine name:
Noroclox DC 500 mg suspensija ievadīšanai tesmenī liellopiem
Active substance:
  • Cloxacillin
Target species:
  • Cattle (dry cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Cloxacillin
    500.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (dry cow)
      • Meat and offal
        28
        day
      • Milk
        28
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51CF02
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Available in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Manufacturing Limited
  • Norbrook Laboratories Limited
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/NRP/96/0443
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 16/08/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 16/08/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 16/08/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."